Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiro Niki

Showing results (11-20 of 205) with videos related to

Pageof 21
Sort By:
Biochemical and Biophysical Research Communications|August 24, 2023
Dual inhibition of KIF11 and BCL2L1 induces apoptosis in lung adenocarcinoma cellsYuji Sakuma, Sachie Hirai, Toshiyuki Sumi, et al.
The American Journal of Surgical Pathology|May 29, 2004
Primary pulmonary paraganglioma: report of a functioning case with immunohistochemical and ultrastructural studyJunji Shibahara, Akiteru Goto, Toshiro Niki, et al.
Pathology International|February 8, 2019
Overexpression of matriptase in tumor stroma is a poor prognostic indicator of extrahepatic bile duct cancerToshihide Komatsubara, Hisashi Oshiro, Yasunaru Sakuma, et al.
The American Journal of Surgical Pathology|September 10, 2020
BRG1, INI1, and ARID1B Deficiency in Endometrial Carcinoma: A Clinicopathologic and Immunohistochemical Analysis of a Large Series From a Single InstitutionAtsushi Kihara, Yusuke Amano, Daisuke Matsubara, et al.
Clinical Immunology (Orlando, Fla.)|April 22, 2011
Galectin-9 administration ameliorates CVB3 induced myocarditis by promoting the proliferation of regulatory T cells and alternatively activated Th2 cellsKun Lv, Wei Xu, Cuini Wang, et al.
The American Journal of Pathology|October 12, 2010
Co-activation of epidermal growth factor receptor and c-MET defines a distinct subset of lung adenocarcinomasDaisuke Matsubara, Shumpei Ishikawa, Oguni Sachiko, et al.
Biochemical and Biophysical Research Communications|September 20, 2022
Dual inhibition of BCL2L1 and MCL1 is highly effective against RET fusion-positive or MET exon 14 skipping mutation-positive lung adenocarcinoma cellsSachie Hirai, Masashi Idogawa, Toshiyuki Sumi, et al.
Human Pathology|July 16, 2021
Infrequent loss of SMARCA4, SMARCA2, and SMARCB1 expression in uterine mesenchymal tumorsAtsushi Kihara, Yusuke Amano, Daisuke Matsubara, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 26, 2010
Molecular predictors of sensitivity to the MET inhibitor PHA665752 in lung carcinoma cellsDaisuke Matsubara, Shumpei Ishikawa, Sachiko Oguni, et al.
Pathology International|November 25, 2003
Lung adenocarcinoma associated with atypical adenomatous hyperplasia. A clinicopathological study with special reference to smoking and cancer multiplicityHiroshi Kitagawa, Akiteru Goto, Toshiro Niki, et al.
Pageof 21

Showing results (11-20 of 205) with videos related to

Sort By:
Pageof 21
Biochemical and Biophysical Research Communications|August 24, 2023
Dual inhibition of KIF11 and BCL2L1 induces apoptosis in lung adenocarcinoma cellsYuji Sakuma, Sachie Hirai, Toshiyuki Sumi, et al.
The American Journal of Surgical Pathology|May 29, 2004
Primary pulmonary paraganglioma: report of a functioning case with immunohistochemical and ultrastructural studyJunji Shibahara, Akiteru Goto, Toshiro Niki, et al.
Pathology International|February 8, 2019
Overexpression of matriptase in tumor stroma is a poor prognostic indicator of extrahepatic bile duct cancerToshihide Komatsubara, Hisashi Oshiro, Yasunaru Sakuma, et al.
The American Journal of Surgical Pathology|September 10, 2020
BRG1, INI1, and ARID1B Deficiency in Endometrial Carcinoma: A Clinicopathologic and Immunohistochemical Analysis of a Large Series From a Single InstitutionAtsushi Kihara, Yusuke Amano, Daisuke Matsubara, et al.
Clinical Immunology (Orlando, Fla.)|April 22, 2011
Galectin-9 administration ameliorates CVB3 induced myocarditis by promoting the proliferation of regulatory T cells and alternatively activated Th2 cellsKun Lv, Wei Xu, Cuini Wang, et al.
The American Journal of Pathology|October 12, 2010
Co-activation of epidermal growth factor receptor and c-MET defines a distinct subset of lung adenocarcinomasDaisuke Matsubara, Shumpei Ishikawa, Oguni Sachiko, et al.
Biochemical and Biophysical Research Communications|September 20, 2022
Dual inhibition of BCL2L1 and MCL1 is highly effective against RET fusion-positive or MET exon 14 skipping mutation-positive lung adenocarcinoma cellsSachie Hirai, Masashi Idogawa, Toshiyuki Sumi, et al.
Human Pathology|July 16, 2021
Infrequent loss of SMARCA4, SMARCA2, and SMARCB1 expression in uterine mesenchymal tumorsAtsushi Kihara, Yusuke Amano, Daisuke Matsubara, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 26, 2010
Molecular predictors of sensitivity to the MET inhibitor PHA665752 in lung carcinoma cellsDaisuke Matsubara, Shumpei Ishikawa, Sachiko Oguni, et al.
Pathology International|November 25, 2003
Lung adenocarcinoma associated with atypical adenomatous hyperplasia. A clinicopathological study with special reference to smoking and cancer multiplicityHiroshi Kitagawa, Akiteru Goto, Toshiro Niki, et al.
Pageof 21